Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
Natural killer group 2 member D (NKG2D) is a type II transmembrane receptor. NKG2D is
present on NK cells in both mice and humans, whereas it is constitutively expressed on …
present on NK cells in both mice and humans, whereas it is constitutively expressed on …
Action and traction: cytoskeletal control of receptor triggering at the immunological synapse
WA Comrie, JK Burkhardt - Frontiers in immunology, 2016 - frontiersin.org
It is well known that F-actin dynamics drive the micron-scale cell shape changes required for
migration and immunological synapse (IS) formation. In addition, recent evidence points to a …
migration and immunological synapse (IS) formation. In addition, recent evidence points to a …
IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer
K Rohena-Rivera, MM Sanchez-Vazquez… - PloS one, 2017 - journals.plos.org
Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer. In the
United States it is second leading cause of cancer related deaths in men. PCa is often …
United States it is second leading cause of cancer related deaths in men. PCa is often …
The actin regulators involved in the function and related diseases of lymphocytes
J Sun, X Zhong, X Fu, H Miller, P Lee, B Yu… - Frontiers in …, 2022 - frontiersin.org
Actin is an important cytoskeletal protein involved in signal transduction, cell structure and
motility. Actin regulators include actin-monomer-binding proteins, Wiskott-Aldrich syndrome …
motility. Actin regulators include actin-monomer-binding proteins, Wiskott-Aldrich syndrome …
Serum cell division cycle 42 reflects the treatment response and survival in patients with advanced cervical cancer who receive immune checkpoint inhibitor treatment
L Guo, Y Su, X Liu, W **e, S Meng, Y Liu… - Oncology …, 2023 - spandidos-publications.com
Abstract Cell division cycle 42 (CDC42) regulates immune escape, which predicts immune
checkpoint inhibitor (ICI) treatment response in several types of cancer. The present study …
checkpoint inhibitor (ICI) treatment response in several types of cancer. The present study …
Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
Antibody therapy targeting cytotoxic T lymphocyte–associated antigen 4 (CTLA4) elicited
survival benefits in cancer patients; however, the overall response rate is limited. In addition …
survival benefits in cancer patients; however, the overall response rate is limited. In addition …
Signal integration during T lymphocyte activation and function: lessons from the Wiskott–Aldrich syndrome
V Cotta-de-Almeida, L Dupré, D Guipouy… - Frontiers in …, 2015 - frontiersin.org
Over the last decades, research dedicated to the molecular and cellular mechanisms
underlying primary immunodeficiencies (PID) has helped to understand the etiology of many …
underlying primary immunodeficiencies (PID) has helped to understand the etiology of many …
Insights into the mechanism for dictating polarity in migrating T-cells
V Niggli - International review of cell and molecular biology, 2014 - Elsevier
This review is focused on mechanisms of chemokine-induced polarization of T-lymphocytes.
Polarization involves, starting from spherical cells, formation of a morphologically and …
Polarization involves, starting from spherical cells, formation of a morphologically and …
An approach to the immunophenotypic features of circulating CD4+NKG2D+ T cells in invasive cervical carcinoma
Background NKG2D, an activating immunoreceptor, is primarily restricted to NK cells and
CD8+ T cells. The existence of an atypical cytotoxic CD4+ NKG2D+ T cell population has …
CD8+ T cells. The existence of an atypical cytotoxic CD4+ NKG2D+ T cell population has …
[HTML][HTML] TGF-β1 expression in regulatory NK1. 1-CD4+ NKG2D+ T cells dependents on the PI3K-p85α/JNK, NF-κB and STAT3 pathways
S Han, S Ding, X Miao, Z Lin, G Lu, W **ao… - American Journal of …, 2018 - ncbi.nlm.nih.gov
Abstract NK1. 1-CD4+ NKG2D+ cells exert their immune-regulatory function in tumor as an
unconventional regulatory T cell subset through the production of TGF-β1; however, the …
unconventional regulatory T cell subset through the production of TGF-β1; however, the …